extract alleviates DSS-induced colitis and regulates gut microbiota in mice.

Ulcerative colitis is a chronic and recurrent gastrointestinal intestinal disease accompanied by inflammatory disorders, immunologic inadequacy, and intestinal flora dysbiosis, and current therapeutic pharmaceuticals have limited side effects. In this study, we revealed the extraction method of , analyzed the main component, compared the effect of its extract, , and conventional drugs with different properties on DSS (dextran sodium sulfate)-induced colitis, and indicated extract regulatory properties of inestinal flora. A colitis model was established on experimental design, and BALB/c mice (male, 7 weeks old) were randomly assigned to five groups ( = 10): control, DSS model, extract (CSE), GG (LGG), and 5-aminosalicylic acid (5-ASA) groups.